DLHCX
Price
$22.05
Change
-$0.02 (-0.09%)
Updated
Feb 21 closing price
Net Assets
742.22M
JNGLX
Price
$71.57
Change
-$0.51 (-0.71%)
Updated
Feb 21 closing price
Net Assets
5B
Ad is loading...

DLHCX vs JNGLX

Header iconDLHCX vs JNGLX Comparison
Open Charts DLHCX vs JNGLXBanner chart's image
Macquarie Healthcare C
Price$22.05
Change-$0.02 (-0.09%)
VolumeN/A
Net Assets742.22M
Janus Henderson Global Life Sciences D
Price$71.57
Change-$0.51 (-0.71%)
VolumeN/A
Net Assets5B
DLHCX vs JNGLX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DLHCX vs. JNGLX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DLHCX is a Buy and JNGLX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
JNGLX has more cash in the bank: 5B vs. DLHCX (742M). JNGLX pays higher dividends than DLHCX: JNGLX (0.12) vs DLHCX (0.00). DLHCX was incepted earlier than JNGLX: DLHCX (15 years) vs JNGLX (26 years). JNGLX is a more actively managed with annual turnover of: 34.00 vs. DLHCX (3.00). DLHCX has a lower initial minimum investment than JNGLX: DLHCX (1000) vs JNGLX (2500). JNGLX annual gain was more profitable for investors over the last year : -3.67 vs. DLHCX (-9.15). JNGLX return over 5 years is better than : 17.54 vs. DLHCX (-12.95).
DLHCXJNGLXDLHCX / JNGLX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence15 years26 years-
Gain YTD5.1005.42194%
Front LoadN/AN/A-
Min. Initial Investment1000250040%
Min. Initial Investment IRAN/AN/A-
Net Assets742M5B15%
Annual Yield % from dividends0.000.12-
Returns for 1 year-9.15-3.67249%
Returns for 3 years-7.2415.97-45%
Returns for 5 years-12.9517.54-74%
Returns for 10 years17.0229.2558%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MGRAX44.46-0.12
-0.27%
MFS International Growth A
DBOCX23.75-0.30
-1.25%
BNY Mellon Balanced Opportunity C
PMPRX15.37-0.29
-1.85%
Principal MidCap Value I R3
TETAX13.61-0.29
-2.09%
RBC Enterprise A
GSXPX54.04-1.36
-2.45%
Goldman Sachs Small Cp Val Insghts P